Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11126
Castor Maritime
CTRM
$22.6M
| $79.7K | ﹤0.01% |
18,879
-308
| -2% | -$1.42K |
|
11127
PUT
LENSAR
LNSR
$102M
| $79.2K | ﹤0.01% |
17,300
-8,000
| -32% | -$37K |
|
11128
OmniAb
OABI
$650M
| $78.8K | ﹤0.01% |
18,628
-18,850
| -50% | -$81.5K |
|
11129
PUT
Sight Sciences
SGHT
$471M
| $78.8K | ﹤0.01% |
12,500
-4,500
| -26% | -$30.3K |
|
|
SUP
11130
DELISTED
Superior Industries International
SUP
| $78.7K | ﹤0.01% |
25,879
+4,218
| +19% | +$13.5K |
|
11131
Franklin Wireless
FKWL
$29.6M
| $78.5K | ﹤0.01% |
17,147
-4,597
| -21% | -$18.7K |
|
11132
Viemed Healthcare
VMD
$336M
| $78.3K | ﹤0.01% |
+10,680
| New | +$76.3K |
|
|
11133
Sight Sciences
SGHT
$471M
| $78.3K | ﹤0.01% |
+12,423
| New | +$83.6K |
|
11134
CALL
D-Wave Quantum Inc
QBTS
$6.33B
| $78K | ﹤0.01% |
79,600
+8,400
| +12% | +$8.4K |
|
|
ARBK
11135
Argo Blockchain
ARBK
$42M
| $77.9K | ﹤0.01% |
298
-31
| -9% | -$8.52K |
|
11136
CALL
AXT Inc
AXTI
$3.84B
| $77.4K | ﹤0.01% |
+32,000
| New | +$90.5K |
|
11137
CALL
James River Group Holdings
JRVR
$191M
| $77.1K | ﹤0.01% |
12,300
-1,100
| -8% | -$8.08K |
|
|
PNNT
11138
PUT
Pennant Park Investment Corp
PNNT
$242M
| $76.9K | ﹤0.01% |
+11,000
| New | +$78.5K |
|
11139
ProQR Therapeutics
PRQR
$323M
| $76.8K | ﹤0.01% |
42,223
-53,895
| -56% | -$101K |
|
11140
CALL
Latham Group
SWIM
$833M
| $76.8K | ﹤0.01% |
+11,300
| New | +$55K |
|
|
NAK
11141
PUT
Northern Dynasty Minerals
NAK
$944M
| $76.8K | ﹤0.01% |
232,700
+59,300
| +34% | +$20.8K |
|
11142
DocGo
DCGO
$39.3M
| $76.7K | ﹤0.01% |
23,111
-99,832
| -81% | -$339K |
|
11143
PUT
Tempest Therapeutics
TPST
$17.5M
| $76.6K | ﹤0.01% |
+4,208
| New | +$86.2K |
|
|
HERZ
11144
Herzfeld Credit Income Fund
HERZ
$32.3M
| $76.1K | ﹤0.01% |
3,367
+594
| +21% | +$13.7K |
|
|
NVRO
11145
CALL
DELISTED
NEVRO CORP.
NVRO
| $76K | ﹤0.01% |
13,600
+100
| +0.7% | +$700 |
|
11146
CALL
Oil States International
OIS
$519M
| $75.9K | ﹤0.01% |
+16,500
| New | +$79K |
|
|
AUTL
11147
Autolus Therapeutics
AUTL
$623M
| $75.2K | ﹤0.01% |
20,704
+301
| +1% | +$1.2K |
|
11148
PUT
Cibus
CBUS
$126M
| $75K | ﹤0.01% |
23,000
-50,400
| -69% | -$365K |
|
11149
CALL
GSI Technology
GSIT
$219M
| $74.7K | ﹤0.01% |
24,500
+9,500
| +63% | +$25.9K |
|
11150
MaxCyte
MXCT
$126M
| $74.7K | ﹤0.01% |
19,209
+2,577
| +15% | +$10.9K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.